Hyperthermia inhibits proliferation and stimulates the expression of differentiation markers in cultured thyroid carcinoma cells
/in International Publications, Thyroid CancerSupplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells
/in International Publications, MicronutrientsPhase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancer
/in Hyperthermia, International Publications, Urothelial CarcinomaFeasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate
/in Hyperthermia, International Publications, Prostate CancerDistribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis
/in Dendritic Cells, International Publications, Urothelial CarcinomaA ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate
/in International Publications, Newcastle Disease VirusTreatment of malignant gliomas with interstitial irradiation and hyperthermia
/in Glioblastoma, Hyperthermia, International Publications[Distribution of S-100 protein-positive dendritic cells in transitional cell carcinoma of human bladder and its relation to clinical prognosis]
/in Dendritic Cells, International Publications, Urothelial CarcinomaA critical look at the subluxation hypothesis
/in International Publications, Newcastle Disease VirusIMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer